Zantac Cancer Lawsuits

Defective Drug Lawyers

Zantac Cancer Lawsuits - Defective Drug Lawyers
The Wieand Law Firm is investigating defective drug claims for the heartburn medication known as Zantac. If you have been diagnosed with kidney, stomach, bladder, colon or pancreatic cancer after taking a brand name prescription or over the counter Zantac, contact a lawyer at the Wieand Law Firm to discuss filing a claim.
We are investigating Zantac cancer lawsuits for people who have developed cancer and have:

  1. taken at least 60 days of regular use of the brand name prescription or over the counter Zantac, or
  2. have regularly taken Zantac for at least one year, if you were diagnosed with cancer over 6 months after your last use of Zantac.

The FDA has been investigating this impurity in other blood pressure medications and some heart failure medications called Angiotensin II Receptor Blockers (ARBs) since last year. The agency determined that the NDMA impurity in ARB’s exceeds safe levels and subsequently issued multiple recalls of these medications.
The U.S. Food and Drug Administration warned that some ranitidine medicines, such as the product commonly known as Zantac, contain a low level of type of nitrosamine impurity known as NDMA. This impurity is a probable carcinogen based on results from laboratory tests. Our defective drug lawyers can help you determine whether you have the right to sue for harms and losses caused by taking Zantac.
If you believe you have developed cancer as a result of taking Zantac you should call a lawyer immediately. There are strict time limitations for filing a lawsuit which varies from state to state.
Zantac is approved to prevent and relieve heartburn due to acid ingestion and sour stomach; in prescription doses, it prevents ulcers of the stomach and intestines and treats gastroesophageal reflux disease.  The FDA has not yet determined if the NMDA exists in the medication due to a flaw in the manufacturing process, or if it stems from the composition of the drug.  The Wieand Law Firm is investigating whether Zantac manufacturers failed to take reasonable precautions to prevent a cancer-causing agents their products.
While the FDA has not yet issued a recall of Zantac and other ranitidine products, the unease has caused concerned pharmacy retailers CVS and Walgreens to pull the products from their shelves.
Consumers who use ranitidine products such as Zantac are urged to be cautious in continuing to use these products and may want to speak with their physician about treatment options. The FDA is encouraging patients taking these products to report adverse reactions to the FDA’s MedWatch program to help the agency ascertain the extent of the problem. In addition, you should speak with a lawyer about the viability a defective drug lawsuit.
If you were diagnosed with cancer after taking Zantac don’t wait to seek legal advice. To discuss your potential Zantac cancer claim with a defective drug lawyer at the Wieand Law Firm call (888) 798-3161 or message us through our online contact form.

Schedule free consultation
Get Started Today!